CYBB and glaucoma: There are however very limited studies on the pharmacological intervention of NOX in animal models of glaucoma and the beneficial effects of NOX inhibition have only been demonstrated with a non-selective NADPH oxidase inhibitor apocynin and NOX2 deficient mice [98].